Antinuclear antibody processing from FPBC (prepared
by expressing blood drops by finger pricking) was standardized
in a pilot study. Paired samples (serum and corresponding
FPBC) from 224 individuals [142 patients of systemic
rheumatic diseases, chiefly lupus and rheumatoid arthritis
(RA) and 82 healthy controls (HC)] were tested by the
standard immunofluorescence (IIF) and IIE (using light
microscope); samples were coded, blinded and randomly
processed as per the protocol. End-point titers were
determined for positive serum samples only. Standard
reagents (Immunoconcepts Incorporation, USA) and controls
(CDC, Atlanta, USA) were used. All patients were identified
in a rheumatology referral practice in an Indian metropolis.
|